5 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary FibrosisFibrosis, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiratory Hypersensitivity, hypersensitivity pneumonitis, immune system disorder, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorderActive, not recruitingPhase 22026-10-05NCT06329401
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorderRecruitingPhase 22026-10-02NCT06951217
Daratumumab in Primary Antiphospholipid Syndromeantiphospholipid syndrome, autoimmune disease, immune system disorderRecruitingPhase 1 / Phase 22026-09-16NCT05671757
Long Term Outcomes of Bariatric Patients Treated With Surgery or EndoscopyBody Weight, Deglutition Disorders, Digestive System Diseases, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, digestive system disorder, dyskinesia of esophagus, esophageal disorder, gastroesophageal reflux disease, nutritional disorder, obesity disorder, overnutritionActive, not recruitingNot stated2026-08-21NCT03705416
Citadel Embolization Device StudyUnruptured Wide-neck AneurysmsActive, not recruitingNot applicable2026-03-30NCT04057352